Wilkins MR - Search Results

1

Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension.

Diller GP, van Eijl S, Okonko DO, Howard LS, Ali O, Thum T, Wort SJ, Bédard E, Gibbs JS, Bauersachs J, Hobbs AJ, Wilkins MR, Gatzoulis MA, Wharton J. Diller GP, et al. Among authors: wilkins mr. Circulation. 2008 Jun 10;117(23):3020-30. doi: 10.1161/CIRCULATIONAHA.108.769646. Epub 2008 Jun 2. Circulation. 2008. PMID: 18519847

2

Recent insights into the pathogenesis and therapeutics of pulmonary hypertension.

Strange JW, Wharton J, Phillips PG, Wilkins MR. Strange JW, et al. Among authors: wilkins mr. Clin Sci (Lond). 2002 Mar;102(3):253-68. Clin Sci (Lond). 2002. PMID: 11869166 Review.

3

Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic Peptide activity.

Zhao L, Mason NA, Strange JW, Walker H, Wilkins MR. Zhao L, et al. Among authors: wilkins mr. Circulation. 2003 Jan 21;107(2):234-7. doi: 10.1161/01.cir.0000050653.10758.6b. Circulation. 2003. PMID: 12538421

4

Pulmonary arterial hypertension and the vasoconstrictive factor: is there still a role for vasodilator testing?

Gibbs JS, Wharton J, Wilkins MR. Gibbs JS, et al. Among authors: wilkins mr. Eur Heart J. 2003 Feb;24(4):297-8. doi: 10.1016/s0195-668x(02)00753-4. Eur Heart J. 2003. PMID: 12581676 No abstract available.

5

Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension.

Sebkhi A, Strange JW, Phillips SC, Wharton J, Wilkins MR. Sebkhi A, et al. Among authors: wilkins mr. Circulation. 2003 Jul 1;107(25):3230-5. doi: 10.1161/01.CIR.0000074226.20466.B1. Epub 2003 Jun 9. Circulation. 2003. PMID: 12796132

6

Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study.

Wilkins MR, Paul GA, Strange JW, Tunariu N, Gin-Sing W, Banya WA, Westwood MA, Stefanidis A, Ng LL, Pennell DJ, Mohiaddin RH, Nihoyannopoulos P, Gibbs JS. Wilkins MR, et al. Am J Respir Crit Care Med. 2005 Jun 1;171(11):1292-7. doi: 10.1164/rccm.200410-1411OC. Epub 2005 Mar 4. Am J Respir Crit Care Med. 2005. PMID: 15750042 Clinical Trial.

7

Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.

Wharton J, Strange JW, Møller GM, Growcott EJ, Ren X, Franklyn AP, Phillips SC, Wilkins MR. Wharton J, et al. Among authors: wilkins mr. Am J Respir Crit Care Med. 2005 Jul 1;172(1):105-13. doi: 10.1164/rccm.200411-1587OC. Epub 2005 Apr 7. Am J Respir Crit Care Med. 2005. PMID: 15817798

8

Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension.

Khoo JP, Zhao L, Alp NJ, Bendall JK, Nicoli T, Rockett K, Wilkins MR, Channon KM. Khoo JP, et al. Among authors: wilkins mr. Circulation. 2005 Apr 26;111(16):2126-33. doi: 10.1161/01.CIR.0000162470.26840.89. Epub 2005 Apr 11. Circulation. 2005. PMID: 15824200

9

Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension.

Paul GA, Gibbs JS, Boobis AR, Abbas A, Wilkins MR. Paul GA, et al. Among authors: wilkins mr. Br J Clin Pharmacol. 2005 Jul;60(1):107-12. doi: 10.1111/j.1365-2125.2005.02383.x. Br J Clin Pharmacol. 2005. PMID: 15963102 Free PMC article.

10

Emerging therapies for pulmonary arterial hypertension.

Ali O, Wharton J, Gibbs JS, Howard L, Wilkins MR. Ali O, et al. Among authors: wilkins mr. Expert Opin Investig Drugs. 2007 Jun;16(6):803-18. doi: 10.1517/13543784.16.6.803. Expert Opin Investig Drugs. 2007. PMID: 17501693 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

579 results

Search Page

Filters